Northwest Biotherapeutics (NWBO) Change in Cash (2010 - 2026)

Northwest Biotherapeutics' Change in Cash history runs 17 years deep, the most recent figure standing at -$1.3 million for Q1 2026.

• In Q1 2026, Change in Cash fell 307.62% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at -$993000.0 (down 429.9% YoY), while the FY2025 annual figure was $865000.0, up 1665.31% from the prior year.
• Change in Cash for Q1 2026 stood at -$1.3 million, up from -$1.5 million in the prior quarter.
• The five-year high for Change in Cash was $4.7 million in Q3 2023, with the low at -$8.2 million in Q1 2022.
• The 5-year median for Change in Cash is -$764000.0 (2024), against an average of -$787235.3.
• The sharpest annual moves came in 2022 and 2026: Change in Cash soared 5789.74% in 2022, then sank 307.62% in 2026.
• Northwest Biotherapeutics' Change in Cash stood at -$2.5 million in 2022, then sank by 61.42% to -$4.0 million in 2023, then soared by 80.76% to -$764000.0 in 2024, then sank by 98.95% to -$1.5 million in 2025, then grew by 17.5% to -$1.3 million in 2026.
• Business Quant data shows NWBO's Change in Cash at -$1.3 million in Q1 2026, -$1.5 million in Q4 2025, and $244000.0 in Q3 2025.